Cidara Therapeutics to Present at the Raymond James Human Health Innovations Conference
Cidara Therapeutics (Nasdaq: CDTX) has announced that its CEO, Jeffrey Stein, Ph.D., will present virtually at the Raymond James Human Health Innovations Conference on June 18, 2020, at 3:40 PM ET. The company focuses on developing long-acting therapeutic solutions for serious fungal and viral infections. Notably, Cidara is advancing its lead Phase 3 antifungal candidate, rezafungin, along with antiviral conjugates from its Cloudbreak antiviral platform. Investors can access the live webcast on the company's website.
- None.
- None.
SAN DIEGO, June 11, 2020 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics to transform the standard of care for patients facing serious fungal or viral infections, today announced that Jeffrey Stein, Ph.D., President and Chief Executive Officer, will present virtually at the Raymond James Human Health Innovations Conference on Thursday, June 18, 2020.
| Presentation Information: | ||
| Date: | Thursday, June 18, 2020 | |
| Time: | 3:40 PM ET | |
| Webcast: | A live audio webcast and replay of the presentation will be available in the Investors section on the Company’s website at www.cidara.com. |
About Cidara Therapeutics
Cidara is developing therapeutics to improve the standard of care for patients facing serious fungal or viral infections. The Company’s portfolio is comprised of breakthrough approaches aimed at transforming existing treatment and prevention paradigms, first with its lead Phase 3 antifungal candidate, rezafungin, in addition to antiviral conjugates (AVCs) targeting influenza and other viral diseases from Cidara’s proprietary Cloudbreak antiviral platform. Cidara is headquartered in San Diego, California. For more information, please visit www.cidara.com.
INVESTOR CONTACT:
Brian Ritchie
LifeSci Advisors
(212) 915-2578
britchie@lifesciadvisors.com
MEDIA CONTACT:
Karen O’Shea, Ph.D.
LifeSci Communications
(929) 469-3860
koshea@lifescicomms.com
FAQ
What is the date of the Cidara Therapeutics presentation at the Raymond James Conference?
What time will Cidara's presentation take place at the conference?
Where can I watch the Cidara Therapeutics presentation?
Who is presenting for Cidara Therapeutics at the conference?
What is the focus of Cidara Therapeutics?
What is Cidara's lead candidate in Phase 3 trials?
